Abbreviations: CCR2, C-C chemokine receptor type 2; CX3CR1, chemokine receptor 1; GI, gastrointestinal tract; HO1, heme oxygenase 1; ICC, interstitial cells of Cajal; IL10, interleukin 10; IL6, interleukin 6; iNOS, Inducible NOS; nNOS, neuronal nitric oxide; NOD, non-obese diabetic; op/op, osteopetrotic mouse; TNFα, tumor necrosis factor-α. 
| INTRODUCTION
Human diabetic and idiopathic gastroparesis and animal models of delayed gastric emptying are characterized by the loss of interstitial cells of Cajal (ICC) as a key cellular abnormality. Previous studies from the NIH Gastroparesis Clinical Research Consortium (GpCRC) have shown a 50% loss of ICC in gastric body muscularis and ultrastructural damage in remaining ICC in the majority of patients with gastroparesis. 1, 2 Other studies also report significant or complete absence of ICC networks. 3, 4 The loss of ICC immunoreactivity (ir) correlated with diabetes severity. 5 Additional cellular abnormalities include loss or damage of nerves or neurons in a subset of patients raising the possibility of a common underlying mechanism of damage to the cell types that regulate gastrointestinal motility. 1, 2, 4 More recently, macrophages have been shown to be critical in the pathophysiology of gastroparesis in animal models. In the non-obese diabetic (NOD) mouse model, development of diabetes was associated with appearance of anti-inflammatory (M2 or alternatively activated, CD206 ir) macrophages. However, gastric emptying delay was evident only after M2 macrophages phenotypically switched to pro-inflammatory (M1 or classically activated) macrophages 6 and ICC were lost. In another study using diabetic, macrophage-deficient CSF1 op/op mice, absence of muscle layer macrophages was protective against the development of delayed gastric emptying. 7 These data suggest that interactions between the innate immune system, specifically macrophages, and ICC and the neuromuscular apparatus may be central in the pathophysiology of human gastroparesis. 8 In our previous study, we provided evidence supporting the existence of this paradigm in the gastric body of patients with diabetic gastroparesis where loss of ICC correlated with the number of M2 macrophages. 9 It was not apparent that the observed changes could be found in other regions of the stomach that are also important for gastric motility such as the antrum. Coordinated activity in the antrum is required for grinding of food particles and passage of food into the duodenum. Postprandial antral hypomotility was observed in over 60% of patients with gastroparesis, and was associated with a significantly lower motility index in patients with autonomic neuropathy. 10 Duplex sonography showed decreased frequency of coordinated antroduodenal contractions and reduced anterograde transpyloric flow in gastroparetic patients with autonomic neuropathy. 11 Gastroparesis patients had a reduced number of antral waves ≥6 cm in duration which correlated with gastric emptying and improved in response to cisapride, a prokinetic agent. 12 In animal models, ICC are more affected in the antrum than the body 13, 14 and gastric antral ICC and stem cell factor expression were found to be reduced in streptozocin-induced diabetic mice. 15 Reduced ICC numbers, structural ICC degeneration, and reduced enteric nerves limited to gastric antrum was associated with delayed gastric emptying in this model.
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The cellular changes in gastric antrum in human gastroparesis are not well known. Therefore, the aim of this study was to determine: (i) if CD206-positive macrophages shown to protect against cellular damage in animal models of gastroparesis are also decreased in the antrum of humans with gastroparesis, (ii) whether there are changes in other cell types known to be important for gastric motility and (iii) the relationship of these cellular findings with clinical symptoms of gastroparesis.
| METHODS

| Specimens
Full thickness gastric antrum biopsies were obtained from 11 diabetic, six idiopathic gastroparesis patients undergoing implantation of a gastric electrical stimulator, and from five controls without diabetes or gastroparesis undergoing obesity surgery. All patients were >18 years of age with symptoms of at least 12-week duration, delayed gastric emptying on scintigraphy (>60% retention at 2 hours or >10% retention at 4 hours), and no evidence of obstruction. Exclusion criteria in- Tyrosine hydroxylase (TH) was used to assess extrinsic sympathetic innervation, Kit to assess ICC, CD45 to assess overall immune cells, and CD206 to assess M2 (alternatively activated) macrophages.
Details on antibodies are provided in Table S1 .
| Quantification
All quantitative assessment was done in a blinded fashion. For PGP9.5
ir fibers (circular muscle), nNOS ir neurons (myenteric plexus) and fibers 
| Gastric emptying
Gastric emptying study was scintigraphy-based using a low-fat egg white meal with imaging at 0, 1, 2, and 4 hours after meal ingestion using the standardized protocol to estimate percent gastric retention.
This protocol ensures standardized information about delayed gastric emptying across all participating sites. 
| Statistical analysis
Quantitative data for c-Kit, PGP, nNOS, VIP, substance P, TH, CD45-ir, and CD206-ir cell bodies are represented as mean±SEM. Statistical significance was determined using the two sided-non-parametric
Mann-Whitney test. Simple Pearson's correlation analysis assuming non-parametric distribution was done to relate the histological markers (as measured) with each other and with symptom severity (overall Gastroparesis Cardinal Symptom Index, GCSI). Spearman r values were reported. A P<.05 was considered statistically significant.
Exact P-values were used and these were not corrected for multiple comparisons. All statistical analyses were carried out using GraphPad 4 software (GraphPad software Inc., La Jolla, CA, USA). Table 1 lists the demographic profile of diabetic and idiopathic gastroparesis patients. Three of the five controls were females and the median age was 51 years (range 39-65 years). The BMI was higher in diabetic gastroparesis as compared to the idiopathic gastroparesis patients. Remaining demographic characteristics, gastric emptying, and symptom severity scores (average GCSI and sub-scores of nausea, fullness, and bloating) were similar in the two groups.
| RESULTS
| Demographic profile
| Gross morphology and assessment of fibrosis
The H&E staining showed normal histology of gastric antrum in all samples and trichrome staining showed no evidence of fibrosis in the gastroparesis biopsies. No difference was noted between diabetic and idiopathic gastroparesis ( Table 2 ). The loss of ICC was uniform throughout the circular muscle.
| Interstitial cells of Cajal
| Enteric nervous system markers
The overall ir for enteric nerves (PGP9. • There is a significant loss of CD206 positive anti-inflammatory macrophages in gastric antrum of patients with diabetic and idiopathic gastroparesis and this correlates with the ICC loss, the key cellular abnormality in gastroparesis.
• Interactions between innate immune cells and other cell types that regulate gastrointestinal motility are important in pathophysiology of gastroparesis and should be further studied. 
| Immune cells and CD206 macrophages
The overall immune cell population was quantified with CD45 (Figure 2 ).
| Correlation between CD206 macrophages and ICC
There was a positive correlation between the CD206 ir cells and ICC (r=.55, P=.008, n=22) ( Figure 3 ). T A B L E 1 Demographic characteristics, clinical symptoms, and gastric emptying of patients with diabetic and idiopathic gastroparesis
| Correlation of cellular changes with clinical symptoms
There was no correlation between the ICC counts and average GCSI 
| Correlation of ICC counts with gastric emptying
There was no correlation between the ICC counts and percent gastric retention at 4 hours in diabetic (r=.10, P=.7) or idiopathic gastroparesis (r=.17, P=.8) ( Figure S4 ).
| DISCUSSION
The pathogenesis of gastroparesis has been obscure but recent experimental studies support an emerging paradigm in which a shift to a pro-inflammatory macrophage phenotype drives loss of ICC and delayed gastric emptying. 8 This manuscript highlights a number of similarities with the findings in animal models but also some differences.
Firstly, this study confirms that the major gastrointestinal cell type associated with the loss of gastric motility in both diabetic and idiopathic gastroparesis is the ICC. This finding has now been reported by several laboratories and appears to involve both the body and antrum of the human stomach. 1, 18, 19 In a study of patients with refractory gastroparesis, ICC loss was present in both diabetic and idiopathic gastroparesis but more profound in idiopathic. 18 Depleted antral ICC correlated with abnormalities on electrogastrogram and poor symptomatic response to gastric electric stimulation. 20 The ICC loss observed in the gastric antrum (>60% loss) in this study is more profound than our previous report in the gastric body (35%-45% loss). 1 These data replicate findings from mouse models observing a greater ICC loss in the gastric antrum than the body. [21] [22] [23] Previously, we have demonstrated significant inverse correlation between ICC counts and 4 hours percent gastric retention in gastric body tissue from diabetic gastroparesis patients (50% diabetic gastroparetics had <3 ICC/field). 24 The more profound nature of ICC loss in gastric antrum (10/11 diabetic gastroparetics had <3 ICC/field) may explain lack of correlation with gastric emptying because beyond a critical loss of ICC, the association with gastric physiology is potentially lost.
The original finding of enteric nerves being preserved in the gastric body in diabetic and idiopathic gastroparesis patients enrolled in the GpCRC appears to extend to the gastric antrum as well. Immunoreactivity for PGP9.5, a general marker for enteric nerves and neurons was found to be unchanged in gastroparesis. Similarly, immunoreactivity for excitatory nerves, inhibitory nerves, and extrinsic sympathetic innervation was also unchanged in gastric antrum. We did not find an association between GCSI scores and ICC or CD206 ir numbers highlighting the multifactorial central and peripheral mechanisms that sustain symptom generation once established by the primary defect. The involvement of macrophages in the development of delayed gastric emptying was initially described in NOD mice. At the onset of diabetes, anti-inflammatory CD206-positive M2 macrophages populate the muscle wall of the stomach of NOD mice, accounting for nearly 80% of all macrophages. 6 However, mice that go on to develop delayed gastric emptying lost their CD206-positive M2 macrophages and expressed M1 macrophages. In contrast to the mouse, the human stomach is populated by a mixture of both CD206-positive and -negative macrophages and rather than absolute loss of a type, the relative number appears to be more important. Nevertheless, our findings are similar in showing a disproportionate loss of CD206 macrophages in patients with gastroparesis. In the antrum, there was a 40%-45% percent loss of CD206 ir cells in circular muscle and >50% loss in the myenteric plexus. This is in contrast to our previous study on gastric body where we did not see an absolute loss of CD206 ir macrophages and suggests a more severe defect in the antrum compared to the body. However, as in this study on the antrum, there was a negative correlation between CD206 macrophage counts and ICC numbers.
Contrary to the previous reports of an immune infiltrate in gast- is robustly expressed in mouse macrophages in inflammation but is epigenetically repressed in human macrophages. 29 Further studies are therefore necessary to identify and validate novel biomarkers for these cell types in human gastric muscularis propria and to count them either by a single or by a combination of antigenic signatures. Our control tissues are derived from obese subjects, however, previously we have found no changes in kit, PGP9.5, and CD45 ir from gastric body tissues of obese and non-obese subjects making it unlikely that obesity has significant impact on gastric ENS and immune cell markers.
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Taken together with the results of experimental studies in mice, the finding that CD206-positive macrophages are decreased in gastroparesis in the antrum suggests that targeting macrophage polarization represents an attractive therapeutic strategy. In NOD mice, up-regulating HO1 in gastric muscularis CD206 macrophages reverses delayed gastric emptying. 30 Carbon monoxide, the product of HO1 activity, has the same effect. 31 IL10 also increases HO1 expression in the gastric body of diabetic NOD mice and recovers delayed gastric emptying, electrical slow wave abnormalities, and ICC networks. 32 This is consistent with the known effects of IL10 in suppressing proinflammatory macrophages and increasing anti-inflammatory macrophages. 33 IL10 is known to be safe for use in humans. 34 The recent demonstration that macrophages are necessary for development of delayed gastric emptying in diabetic mice 7 also suggests that neutralizing the pro-inflammatory cytokines generated by conventionally activated, M1-like macrophages may also serve as a treatment opportunity.
In summary, our findings show that the major gastrointestinal cellular defect in the antrum of patients with diabetic and idiopathic gastroparesis is loss of ICC. Secondly, there is a profound loss of antiinflammatory macrophages in the antrum of both diabetic and idiopathic gastroparesis patients. Further, there is a correlation between ICC and CD206 ir macrophage numbers suggesting that ICC loss may be the result of loss of the anti-inflammatory macrophage subtype.
Finally, there is no change in the density of the nerves in the gastric antrum in either diabetic or idiopathic gastroparesis. Overall, these findings provide pathophysiological insights for human gastroparesis being driven by interactions between the innate immune system and ICC and provide a potential rationale for targeting macrophages and the associated inflammatory milieu for the treatment of gastroparesis.
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